GW Pharmaceuticals reported deeper-than-expected losses Tuesday and guided to flat first-quarter sales of its seizure medicine, Epidiolex, — prodding GWPH stock to topple Wednesday. Read More...
Why A CBD-Oil Seizure Drug Will Make — Or Break — This Biotech Stock
GW Pharmaceuticals reported deeper-than-expected losses Tuesday and guided to flat first-quarter sales of its seizure medicine, Epidiolex, — prodding GWPH stock to topple Wednesday.
Add Comment